Item 16. Form 10-K Summary

3K characters. Original on sec.gov · Markdown

Item 16. Form 10-K Summary

Form 10-K Summary

None.

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange

Act of 1934, the Registrant has duly

caused this report to be signed on its behalf by the undersigned,

thereunto duly authorized.

Henry Schein, Inc.

By: /s/ STANLEY M. BERGMAN

Stanley M. Bergman

Chairman and Chief Executive Officer

February 17, 2021

Pursuant to the requirements of the Securities Exchange Act of 1934, this

report has been signed below by the

following persons on behalf of the Registrant and in the capacities and on

the dates indicated.

Signature

Capacity

Date

/s/ STANLEY M. BERGMAN

Chairman, Chief Executive Officer

February 17, 2021

Stanley M. Bergman

and Director (principal executive officer)

/s/ STEVEN PALADINO

Executive Vice President,

Chief Financial Officer

February 17, 2021

Steven Paladino

and Director (principal financial and accounting officer)

/s/ JAMES P.

BRESLAWSKI

Vice Chairman, President

and Director

February 17, 2021

James P.

Breslawski

/s/ GERALD A. BENJAMIN

Director

February 17, 2021

Gerald A. Benjamin

/s/ MARK E. MLOTEK

Director

February 17, 2021

Mark E. Mlotek

/s/ MOHAMAD ALI

Director

February 17, 2021

Mohamad Ali

/s/ BARRY J. ALPERIN

Director

February 17, 2021

Barry J. Alperin

/s/ PAUL

BRONS

Director

February 17, 2021

Paul Brons

/s/ DEBORAH DERBY

Director

February 17, 2021

Deborah Derby

/s/ SHIRA GOODMAN

Director

February 17, 2021

Shira Goodman

/s/ JOSEPH L. HERRING

Director

February 17, 2021

Joseph L. Herring

/s/ KURT P.

KUEHN

Director

February 17, 2021

Kurt P.

Kuehn

/s/ PHILIP A. LASKAWY

Director

February 17, 2021

Philip A. Laskawy

/s/ ANNE H. MARGULIES

Director

February 17, 2021

Anne H. Margulies

/s/ CAROL RAPHAEL

Director

February 17, 2021

Carol Raphael

/s/ E. DIANNE REKOW

Director

February 17, 2021

E. Dianne Rekow,

DDS, Ph.D.

/s/ BRADLEY T. SHEARES,

PH. D.

Director

February 17, 2021

Bradley T. Sheares,

Ph. D.

Schedule II

Valuation

and Qualifying Accounts

(in thousands)

Additions (Reductions)

Charged

Balance at

Charged to

(credited) to

Balance at

beginning of

statement of

other

end of

Description

period

income (1)

accounts (2)

Deductions (3)

period

Year

ended December 26, 2020:

Allowance for doubtful accounts

and other

$

60,002

$

35,137

$

$

(7,839)

$

88,030

Yea

r

ended December 28, 2019:

Allowance for doubtful accounts

and other

$

53,121

$

12,612

$

$

(5,865)

$

60,002

Yea

r

ended December 29, 2018:

Allowance for doubtful accounts

and other

$

46,261

$

14,384

$

(1,158)

$

(6,366)

$

53,121

(1)

Represents amounts charged to bad debt expense.

(2)

Amounts charged (credited) to other accounts primarily relate to provision for late fees and the impact

of foreign currency exchange rates and

the adoption of ASU No. 2016-13 effective December 29, 2019.

(3)

Deductions primarily consist of fully reserved accounts receivable that have been written off.

Previous: Item 15. Exhibits, Financial Statement Schedules